These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5516219)

  • 1. [Comparative clinical characteristics of the cutaneous form of anthrax among adults and children vaccinated and unvaccinated with STI vaccine].
    Baĭgel'dieva AB
    Sov Zdravookhr Kirg; 1970; 6():40-3. PubMed ID: 5516219
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthrax vaccination in the Millennium Cohort: validation and measures of health.
    Smith B; Leard CA; Smith TC; Reed RJ; Ryan MA;
    Am J Prev Med; 2007 Apr; 32(4):347-53. PubMed ID: 17383567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthrax. Biological and immunological principles of diagnosis and prevention. 4. The dynamics and intensity of skin tests with anthraxin in guinea pigs inoculated with a STI vaccine.
    Shlyakhov EN
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):464-8. PubMed ID: 4992904
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):341-5. PubMed ID: 10817479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delayed hypersensitivity after anthrax vaccination. I--Study of guinea pigs vaccinated against anthrax].
    Shlyakhov E; Rubinstein E
    Med Trop (Mars); 1994; 54(1):33-7. PubMed ID: 8196523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post anthrax vaccine delayed hypersensitivity. II--delayed hypersensitivity in humans vaccinated against anthrax].
    Shlyakhov E; Rubinstein E
    Med Trop (Mars); 1994; 54(2):133-6. PubMed ID: 7934778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anthrax.
    Gold H
    Fed Proc; 1967 Sep; 26(5):1563-8. PubMed ID: 6051335
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.
    Semenova VA; Schmidt DS; Taylor TH; Li H; Steward-Clark E; Soroka SD; Ballard MM; Quinn CP
    Vaccine; 2007 Feb; 25(10):1780-8. PubMed ID: 17229495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel vaccines against anthrax in man.
    Stepanov AV; Marinin LI; Pomerantsev AP; Staritsin NA
    J Biotechnol; 1996 Jan; 44(1-3):155-60. PubMed ID: 8717399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women.
    Zhang Y; Martin SW; Rose CE; Biagini RE; Franzke LH; Smith JP; Sammons DL; Robertson SA; McNeil MM
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1060-7. PubMed ID: 18781705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed hypersensitivity in man after booster anthrax vaccination].
    Shlyakhov E; Rubinstein E
    Med Trop (Mars); 1996; 56(2):148-50. PubMed ID: 8926874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
    Flick-Smith HC; Waters EL; Walker NJ; Miller J; Stagg AJ; Green M; Williamson ED
    Microb Pathog; 2005 Jan; 38(1):33-40. PubMed ID: 15652293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of STI vaccine acceptability among parents and their adolescent children.
    Zimet GD; Perkins SM; Sturm LA; Bair RM; Juliar BE; Mays RM
    J Adolesc Health; 2005 Sep; 37(3):179-86. PubMed ID: 16109336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques.
    Klinman DM; Xie H; Little SF; Currie D; Ivins BE
    Vaccine; 2004 Jul; 22(21-22):2881-6. PubMed ID: 15246624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
    Bienek DR; Chang CK; Cohen ME
    Vaccine; 2007 Aug; 25(32):5978-84. PubMed ID: 17597265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program.
    Fowler GL; Baggs JM; Weintraub ES; Martin SW; McNeil MM; Gust DA
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):880-8. PubMed ID: 16924600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines: countering anthrax: vaccines and immunoglobulins.
    Grabenstein JD
    Clin Infect Dis; 2008 Jan; 46(1):129-36. PubMed ID: 18171228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.